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Summary
Capripoxviruses, comprising sheep pox virus, goat pox virus and lumpy skin dis-
ease virus cause serious diseases of domesticated ruminants, notifiable to The
World Organization for Animal Health. This report describes the evaluation of a
mobile diagnostic system (Enigma Field Laboratory) that performs automated
sequential steps for nucleic acid extraction and real-time PCR to detect capripox-
virus DNA within laboratory and endemic field settings. To prepare stable
reagents that could be deployed into field settings, lyophilized reagents were used
that employed an established diagnostic PCR assay. These stabilized reagents
demonstrated an analytical sensitivity that was equivalent, or greater than the
established laboratory-based PCR test which utilizes wet reagents, and the limit of
detection for the complete assay pipeline was approximately one log10 more sensi-
tive than the laboratory-based PCR assay. Concordant results were generated
when the mobile PCR system was compared to the laboratory-based PCR using
samples collected from Africa, Asia and Europe (n = 10) and experimental studies
(n = 9) representing clinical cases of sheep pox, goat pox and lumpy skin disease.
Furthermore, this mobile assay reported positive results in situ using specimens
that were collected from a dairy cow in Morogoro, Tanzania, which was exhibit-
ing clinical signs of lumpy skin disease. These data support the use of mobile PCR
systems for the rapid and sensitive detection of capripoxvirus DNA in endemic
field settings.
Capripoxviruses (CaPVs) cause serious pox diseases of
domesticated ruminants (Carn, 1993). Comprising sheep
pox virus (SPPV), goat pox virus (GTPV) and lumpy skin
disease virus (LSDV), they are large, complex, double-
stranded DNA viruses within the genus Capripoxvirus, sub-
family Chordopoxvirinae, family Poxviridae (Buller et al.,
2005). SPPV and GTPV are normally restricted to Asia and
North Africa, although clinical cases of sheep pox have also
been detected in Europe (Mangana et al., 2008), and
recently in Bulgaria and Greece (during 2013). Lumpy skin
disease (LSD) occurs across Africa, and in recent years,
LSDV has also been found in several countries of the
Middle East (Tuppurainen and Oura, 2012), including Tur-
key where more than 236 outbreaks have occurred since
2013 (ProMed 20130831.1915595).
The World Organization for Animal Health (OIE) classi-
fies CaPVs as notifiable disease agents, and molecular diag-
nostic tests play an important role in monitoring the
spread of these viruses in susceptible livestock. A range of
conventional agarose-gel-based polymerase chain reaction
(PCR) assays (Ireland and Binepal, 1998; Heine et al., 1999;
Markoulatos et al., 2000; Tuppurainen et al., 2005; Zheng
et al., 2007), or real-time PCR assays (Balinsky et al., 2008;
Bowden et al., 2008; Stubbs et al., 2012) are used in
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diagnostic laboratories. However, poorly equipped labora-
tories often face difficulties accessing these molecular tech-
niques (particularly real-time PCR) that are reliant upon
expensive and relatively fragile equipment. In particular,
the ability to perform nucleic acid-based tests such as PCR
in field settings has proven to be a challenging goal largely
due to the reliance upon pre-processing of samples (nucleic
acid extraction), the lack of stable reagents that are suitable
for use in environments where it is not possible to maintain
a cold chain (King et al., 2008) and the cost of the field
equipment. The Enigma Field Laboratory (FL) is a hard-
ware platform which undertakes nucleic acid extraction,
PCR thermocycling and analysis of data without user inter-
vention, which has been applied for the detection of other
notifiable diseases such as foot-and-mouth disease (Madi
et al., 2012). The aim of this study was to optimize and
evaluate a mobile PCR platform for the simple detection of
CaPV DNA.
This study utilized the real-time PCR primers, probes,
master mixes and cycling conditions that have been previ-
ously described (Bowden et al., 2008). Pilot studies were
undertaken to assess the performance of newly developed
lyophilized PCR reagents that were prepared and assem-
bled into assay cartridges by Enigma Diagnostics (Salis-
bury, UK). A decimal dilution series (Neat to 1010) of
DNA prepared from an LSDV isolate (Israel LSD-07 POX-
V1-07-08, isolated from naturally infected cattle in 2007)
was prepared in nuclease-free water containing carrier
RNA (1 lg ml1). In these experiments, 5 ll of each dilu-
tion was mixed with 20 ll of nuclease-free water and this
was used to re-suspend the lyophilized reagent pellets
prepared by Enigma Diagnostics. This 25 ll suspension
was then transferred into a 96-well PCR plate. For the
conventional wet reagents, 2 ll of DNA was added to
18 ll of diagnostic assay mastermix (Bowden et al., 2008)
prior to transfer into 96-well PCR plate. This initial labo-
ratory validation of lyophilized reagents was carried out
on the Mx3005P quantitative PCR machine (Stratagene).
Parallel testing demonstrated an improved analytical sensi-
tivity of one log10 for the lyophilized reagents when com-
pared to the reference test (Fig. 1a). This one log10
increase in analytical sensitivity was maintained when the
new lyophilized assay was applied to a decimal dilution
series (101–1010) of Israel LSD-07 POX-V1-07-08 virus
prepared in 10% w/v homogenized cattle skin suspensions
and run in full, including DNA extraction on the Enigma
FL (Fig. 1b). For the above comparison, one aliquot per
dilution was extracted on the MagNA Pure LC Robot
(Roche) using the Total Nucleic Acid Isolation kit (Roche)
following manufacturer guidelines, followed by real-time
PCR performed using wet reagents assayed on the
Mx3005P quantitative PCR machine (Stratagene) (refer-
ence test). The extraction and real-time PCR for the sec-
ond aliquot (0.5 ml) was performed in a complete
automated cycle on the Enigma FL.
The suitability of this assay to detect CaPV DNA in clini-
cal samples was evaluated using archived field and experi-
mental samples held at the OIE Reference Laboratory for
LSDV and GPV/SPV (The Pirbright Institute, UK) and the













































Fig. 1. Comparative analytical sensitivity of the lyophilized PCR assay used to detect CaPV DNA. (a) A decimal dilution series of CaPV DNA (isolate
Israel LSD-07 POX-V1-07-08) tested using wet reagents (●) and lyophilized reagents (○) with a laboratory-based PCR machine (Mx3005P, Strata-
gene). Points represent mean CT from duplicate determinations where the maximum CT range of duplicates was 1.53. (b) Comparison of a decimal
dilution series of a CaPV isolate DNA (Israel LSD-07 POX-V1-07-08) spiked into skin suspensions assayed using wet PCR reagents (○, Mx3005P) com-
pared to lyophilized PCR reagents and nucleic acid extraction employed on the Enigma FL (●). Points represent mean CT from duplicate determina-
tions for the wet PCR assay (* data point represents a single where the duplicate sample generated a no CT result), while only single values are shown
for the samples tested on the Enigma FL.
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(Tanzania Veterinary Laboratories Agency-TVLA). Four-
teen clinical samples (Table 1), comprising nine from two
experimentally infected animals where cattle had been
infected with LSDV Neethling strain (VN83 and VN84),
and five from field samples submitted to The Pirbright
Institute were used. Five additional skin scrapings from the
TVLA archive were analysed within East African laboratory
settings. For each sample, one duplicate was extracted and
assayed using the established reference test (Bowden et al.,
2008) whilst for the second duplicate the extraction and
real-time PCR was performed on the Enigma FL. There was
complete concordance between positive results (n = 19)
and negative results (n = 3) generated on the Enigma FL
and the standard laboratory pipelines (Table 1). Oppor-
tunistic testing of samples collected from a Holstein–Frie-
sian cross-dairy cow on a small holder farm in Morogoro,
Tanzania, displaying clinical signs of LSD (Fig. 2) was also
undertaken. Two samples comprising EDTA blood and
skin scrapings were tested; skin scrapings were processed
using a field-based tissue processing kit (Svanodip Ag
extraction kit; prior to being added into the Engima FL
sample loading chamber, whilst EDTA blood was added
directly to the sample chamber). Both specimens were posi-
tive for CaPV DNA using the Enigma FL. It should be
noted that the current diagnostic reference test (Bowden
et al., 2008) utilizes a conservative cut-off CT value of <37
to define a positive result. However, for this study, all CT
values are reported because amplification of CaPV in ani-
mals with late infection may generate weak values that
would be missed with a cut-off of 37. Suitable negative con-
trols were also included in the data set to confirm the
absences of any false amplification.
Table 1. Performance of the lyophilized PCR system (Enigma FL) compared to the laboratory-based PCR pipeline (Reference Test) using clinical sam-
ples collected from field cases and experimental infection studies
Sample ID Species Sample type Enigma FL CT Reference test CT
Experimental infection VN83 11DPI Cattle Blood 33 35.74
VN83 14DPI Cattle Ocular 39 35.93
VN83 16DPI Cattle Saliva 43 33.38
VN83 25DPI Cattle Nasal 36 32.90
VN83 28DPI Cattle Saliva 39 33.83
VN83 37DPI Cattle Scabs 18 15.71
VN84 12DPI Cattle Blood 34 34.71
VN84 14DPI Cattle Ocular 38 34.86
VN84 22DPI Cattle Scabs 17 16.91
Field samples BUL/V713-1 2013 Sheep Blood 34 29.96
BUL/V713-3 2013 Sheep Blood 33 28.93
MON/V107-1 2007 Sheep Blood 16 11.50
MON/V107-3 2007 Sheep Scabs 16 12.53
VIET/21030-2 2005 Goat Scabs 22 18.99
TAN/TVLA 1 GRSa Cattle Scabs 16 16.12
TAN/TVLA 2 NSa Cattle Scabs 31 31.23
TAN/TVLA 3 MRa Cattle Scabs 26 26.34
TAN/TVLA 4 MSa Cattle Scabs 18 18.18
TAN/TVLA 5 GMa Cattle Scabs 34 34.14
TAN/Morogorob Cattle Blood 35 Not tested
TAN/Morogorob Cattle Scabs 19 Not tested
Control UKG Negative Cattle Blood No CT No CT
UKG Negative Sheep Blood No CT No CT
UKG Negative Cattle Skin No CT No CT
aFive samples were skin nodule scrapings from separate cattle with clinical LSD from Mwika Village, Kilimanjaro, Tanzania.
bField samples from Morogoro, Tanzania, collected and analysed in situ.
Fig. 2. Holstein–Friesian cross-dairy cow displaying clinical signs of
lumpy skin disease (LSD) on a farm in Morogoro, Tanzania, from which
field samples (EDTA blood and skin nodule scrapings) were tested.
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These data show that a mobile PCR platform can rapidly
detect CaPVs from suspect cases, within 60 minutes of
sample collection, offering a sensitive molecular technology
that can be deployed into field settings. Furthermore, the
comparative data for the lyophilized reagents demonstrate
that it is possible to generate a stabilized assay with equiva-
lent (or better) performance compared with the wet-assay
format. This current assay format represents the results of a
collaborative research project that was undertaken to high-
light the potential of these technologies for diagnostic use.
Future validation to include a greater sample data set
would increase confidence in the test and could be
combined with optimization of the DNA extraction steps
to bring its performance in line with that of a standard
laboratory extraction robot. Further availability of this par-
ticular assay (via commercial sources), as well as other tests
that might also exploit this format, will be dependent upon
demand and interest from customers.
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